November 6 (SeeNews) - Croatian pharmaceuticals producer Jadran Galenski Laboratorij (JGL) [ZSE:3JDG2] said on Wednesday that it has set up a fully-owned subsidiary in Bosnia and sold its existing affiliate company there in a move to consolidate its marketing and sales activities in the country.